A high-risk, high-reward bet on next-generation oncolytic and antiviral therapies

Ruvidar and Rutherrin show strong potential in treating bladder cancer, solid tumors, and HSV-1—including drug-resistant ...

New biosensor technology maps enzyme mystery inside cells

Cornell researchers have developed a powerful new biosensor that reveals, in unprecedented detail, how and where ...

'Switchbody' turns enzyme activity on with antibody–antigen binding

By fusing enzyme fragments to antibodies, researchers from the Institute of Science Tokyo, in Japan, developed an innovative enzyme switch called "Switchbody," which is activated when bound to its ...

Potential cause of unexplained diseases suffered by millions of Americans discovered by scientists... leading the way to cures

Scientists have pinpointed a previously unknown cellular breakdown that triggers multiple severe genetic diseases.
IEEE

KNEE-HAR: A ConvLSTM-Based Lightweight Hybrid Deep-Learning Model for Human Activity Recognition With Knee Abnormalities Using Raw Physiological Sensor Data

Abstract: Human activity recognition (HAR) is one of the most exploited areas in the field of artificial intelligence and wearable sensor technology. Most of the work on HAR classifies simple to ...
Anadolu Ajansi

OPINION - Rebuilding Gaza and the roadmap for key actors

Over the past two years, Gaza has witnessed a genocide and one of the most devastating acts of destruction in modern history by Israel, watched live by the entire world. Nearly two million people were ...
C&EN

Development of Selective and Soluble Mitochondrial Complex 1 Inhibitors Derived from Papaverine for Radiosensitization of Cancer

Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio 43210, United States ...